Literature DB >> 3710189

Complications of local beta radiation of uveal melanomas.

M H Foerster, N Bornfeld, U Schulz, A Wessing, G Meyer-Schwickerath.   

Abstract

The results of local beta ray radiation of 295 eyes containing a uveal melanoma (including 74 melanomas of the anterior choroid and ciliary body) are presented with special respect to the complications of treatment. The most frequent complications were radiation retinopathy and optic neuropathy. Complications known to occur from other radiation methods, such as dry eye syndrome, loss of cilia, and scleral necrosis, did not occur in our series. The incidence of radiation cataract, as compared to the treatment with 60Co plaques, was lower in our series. An average of 700 Gy delivered to the scleral base of the tumor was needed for uveal melanomas which could be destroyed. This radiation dose resulted in a 10% incidence of radiation retinopathy.

Entities:  

Mesh:

Year:  1986        PMID: 3710189     DOI: 10.1007/bf02150026

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  18 in total

Review 1.  Treatment of choroidal melanomas with 106Ru/106Rh beta-ray applicators.

Authors:  P Lommatzsch
Journal:  Surv Ophthalmol       Date:  1974 Sep-Oct       Impact factor: 6.048

2.  Ocular complications after therapeutic irradiation.

Authors:  P A Macfaul; M A Bedford
Journal:  Br J Ophthalmol       Date:  1970-04       Impact factor: 4.638

3.  [The treatment of melanoma of the choroid using localized radiation of cobalt 60 applicators (author's transl)].

Authors:  L Zografos; C Gailloud
Journal:  Klin Monbl Augenheilkd       Date:  1979-06       Impact factor: 0.700

4.  Current results of proton beam irradiation of uveal melanomas.

Authors:  E S Gragoudas; J Seddon; M Goitein; L Verhey; J Munzenrider; M Urie; H D Suit; P Blitzer; A Koehler
Journal:  Ophthalmology       Date:  1985-02       Impact factor: 12.079

5.  Radiation optic neuropathy.

Authors:  G C Brown; J A Shields; G Sanborn; J J Augsburger; P J Savino; N J Schatz
Journal:  Ophthalmology       Date:  1982-12       Impact factor: 12.079

6.  Radiation retinopathy.

Authors:  G C Brown; J A Shields; G Sanborn; J J Augsburger; P J Savino; N J Schatz
Journal:  Ophthalmology       Date:  1982-12       Impact factor: 12.079

7.  Cobalt plaque therapy of posterior uveal melanomas.

Authors:  J A Shields; J J Augsburger; L W Brady; J L Day
Journal:  Ophthalmology       Date:  1982-10       Impact factor: 12.079

8.  Retinal vascular remodelling in radiation retinopathy.

Authors:  K G Noble; M J Kupersmith
Journal:  Br J Ophthalmol       Date:  1984-07       Impact factor: 4.638

9.  beta-Irradiation of choroidal melanoma with 106Ru/106Rh applicators. 16 Years' experience.

Authors:  P K Lommatzsch
Journal:  Arch Ophthalmol       Date:  1983-05

10.  Radiotherapy of choroidal melanoma with iodine-125.

Authors:  S Packer; M Rotman
Journal:  Ophthalmology       Date:  1980-06       Impact factor: 12.079

View more
  7 in total

1.  Calcification-like echographic patterns in uveal melanomas treated with brachytherapy.

Authors:  U Kellner; M H Foerster; N Bornfeld
Journal:  Br J Ophthalmol       Date:  1993-12       Impact factor: 4.638

2.  Concurrent versus sequential application of ferromagnetic hyperthermia and 125I brachytherapy of melanoma in an animal model.

Authors:  W F Mieler
Journal:  Trans Am Ophthalmol Soc       Date:  1997

3.  Microwave plaque thermoradiotherapy for choroidal melanoma.

Authors:  P T Finger
Journal:  Br J Ophthalmol       Date:  1992-06       Impact factor: 4.638

4.  Radiation related complications after ruthenium plaque radiotherapy of uveal melanoma.

Authors:  P Summanen; I Immonen; T Kivelä; P Tommila; J Heikkonen; A Tarkkanen
Journal:  Br J Ophthalmol       Date:  1996-08       Impact factor: 4.638

5.  Histopathology studies in human malignant melanomas of the choroid after unsuccessful treatment with 106Ru/106Rh ophthalmic applicators.

Authors:  H Klaus; P K Lommatzsch; U Fuchs
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

6.  Ruthenium-106 plaque brachytherapy for symptomatic vasoproliferative tumours of the retina.

Authors:  G Anastassiou; N Bornfeld; A O Schueler; H Schilling; S Weber; D Fluehs; B Jurklies; O Vij; W Sauerwein
Journal:  Br J Ophthalmol       Date:  2006-04       Impact factor: 4.638

7.  Radiation-induced optic neuropathy following brachytherapy of uveal melanomas.

Authors:  U Kellner; N Bornfeld; M H Foerster
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-05       Impact factor: 3.117

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.